SEATTLE, Oct. 14, 2014 /PRNewswire-USNewswire/ -- The Epilepsy Foundation Northwest announces two regional conferences in November celebrating National November Epilepsy Awareness Month. The conferences will be held in Seattle, WA and Spokane, WA, and are free and open to the public. The conference in Seattle will be on Saturday, November 8 at the Wright Auditorium at Seattle Children's Hospital from 8:30 am to 4:30 pm. Keynote speaker, Dr. Jeffrey Bucchalter, Director of the Comprehensive Children's Epilepsy Center at Alberta Children's Hospital. Dr. Bucchalter will speak on Sudden Unexpected Death in Epilepsy (SUDEP) A Conversation Based on Risk and Empathy. SUDEP is the leading cause of premature death among people with epilepsy, and topic gaining more attention in research and patient-provider relationships. Use of marijuana in treatment of epilepsy, "Medical Marijuana: Current Impacts on Epilepsy Treatment" will be presented by Dr. Russell Saneto of Seattle Children's Hospital. Other conference presentation topics include "Sleep and Impacts on Epilepsy," "Anti-Seizure Medication," "Infants/Preschool Age Children with Epilepsy," and a panel of medical professionals for a question and answer period. To register for the Seattle Conference go to: http://www.SeattleConference.org. (The Seattle Conference will also be available in webcast.) The conference in Spokane will be held … Continue reading →

DES MOINES | A legislative panel Tuesday cleared state rules to take effect Jan. 30 governing registration cards for Iowans authorized to possess marijuana-derived cannabis oil for treatment of epilepsy. However, Deborah Thompson, policy adviser for the Iowa Department of Public Health, said her agency and the state Department of Transportation may not be in a position to actually issue the photo ID registration cards until a later date after the rules have taken effect. DOT officials have been working with a vendor to produce the cards, part of a new state law that allows limited access to medical cannabidiol, she said. State officials are treating the cards as a priority project as they push for a launch date to physically issue the cards. We just want to make sure that all of the pieces are there, Thompson said. I would like to think well know closer to the date what everything looks like. It is likely that the health agency will post an application form online in advance of the card issuance so patients and parents of minor patients can submit the information needed from a licensed neurologist to qualify. However, the bigger issue facing families of epileptic patients … Continue reading →

Galway, Ireland (PRWEB) October 15, 2014 Neuravi, a developer of innovative minimally invasive stroke therapy solutions, announced today that the U.S. Patent Office has approved two patents covering its therapeutic platform for the endovascular treatment of acute ischemic stroke. The granting of U.S. Patent #8,852,205 Clot Retrieval Device for Removing Occlusive Clot from a Blood Vessel and U.S. Patent #8,777,976 B2 Clot Capture Systems and Associated Methods expands Neuravis US granted portfolio to 33 patents. These new patents disclose unique design elements intended to enable both clot disengagement and capture and so facilitate the protected removal of hazardous clot from the brain.The CE-marked Embotrap Revascularization System incorporates these advanced features into its design. According to David Vale, Chief Technology Officer for Neuravi, the company has established its extensive portfolio by a combination of external licensing and internal R&D. This approach has given us a great combination of very early priority filings on the base technology as well as strong protection on the more advanced 3rdgeneration features. The extensive Neuravi patent portfolio continues to be strengthened by our R&D teams commitment to developing technologies that tackle some of the most daunting clinical challenges in treating this patient population, said David. The … Continue reading →